卡纳塔卡为血友病患者提供免费的Emicizumab治疗,报销费用和提供救护车。 Karnataka offers free Emicizumab treatment to haemophilia patients, covering costs and providing ambulances.

卡纳塔卡启动了“Kusuma Sanjeevini”计划, 免费为血友病患者提供Emicizumab治疗, Karnataka has launched the 'Kusuma Sanjeevini' program, providing free access to Emicizumab treatment for haemophilia patients, becoming one of the first large Indian states to do so. 该倡议由45.55卢比供资,用于每名病人每年约5万卢比的治疗费用,包括108个免费救护车服务。 The initiative, funded with Rs 45.55 crore, covers annual treatment costs of about Rs 5 lakh per patient and includes free 108 ambulance services. 它旨在为大约2 600名经鉴定的病人(主要是男性)提供支助,每月提供次肾注射,以减少出血,提高生活质量。 It aims to support around 2,600 identified patients, primarily males, by offering a monthly subcutaneous injection that reduces bleeding episodes and improves quality of life. 对200名据报零出血的病人进行了测试,取代了每周痛苦的静脉注射,使儿童能够上学和参加日常活动。 The treatment, tested on 200 patients with zero bleeds reported, replaces painful weekly intravenous infusions and enables children to attend school and participate in daily activities. 官员称其为公共医疗保健和社会包容方面的一个重大步骤。 Officials call it a major step in public healthcare and social inclusion.